FMCRX | FSMDX | FMCRX / FSMDX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 13 years | - |
Gain YTD | 16.075 | 16.839 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 312M | 36.4B | 1% |
Annual Yield % from dividends | 1.12 | 1.28 | 88% |
Returns for 1 year | 16.60 | 30.65 | 54% |
Returns for 3 years | -19.14 | 12.62 | -152% |
Returns for 5 years | -6.72 | 63.94 | -11% |
Returns for 10 years | -27.25 | 137.58 | -20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSVIX | 13.93 | 0.18 | +1.31% |
Mesirow Small Company Institutional | |||
FBTIX | 37.68 | 0.39 | +1.05% |
Fidelity Advisor Biotechnology I | |||
MLNAX | 23.62 | 0.16 | +0.68% |
Morgan Stanley Instl Glbl Concntr A | |||
PSPJX | 28.38 | 0.13 | +0.46% |
Principal Large Cap S&P 500 Index J | |||
GWETX | 32.73 | N/A | N/A |
AMG GW&K Small Cap Core N |